Fig. 3From: Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer CentreFive-year OS all causes by (a) modality of 1st LoT (n = 181), b de novo or recurrent metastatic status (n = 196), c site of metastasis (n = 192), d age group (n = 196), e site of metastasis by age group (n = 192) and f site of metastasis by metastatic status (n = 192)Back to article page